Healthy Eating: Understanding the Nutrition Facts Label by Linda Bobroff, Karla P. Shelnutt

“… The U.S. Food and Drug Administration (FDA) requires that most food packages have the Nutrition Facts label. …”
Get full text

How the Veterinary Feed Directive Affects Cattle Owners by Matt Hersom, Todd Thrift, Joel Yelich

“… The Veterinary Feed Directive (VRD) is a federal regulation from the Food and Drug Administration that will change the additives that can be included in animal feed, the ways in which cattle producers manage their animals and veterinarians interact with cattle owners, and the products available for use on the ranch. …”
Get full text

How the Veterinary Feed Directive Affects Cattle Owners by Matt Hersom, Todd Thrift, Joel Yelich

“… The Veterinary Feed Directive (VRD) is a federal regulation from the Food and Drug Administration that will change the additives that can be included in animal feed, the ways in which cattle producers manage their animals and veterinarians interact with cattle owners, and the products available for use on the ranch. …”
Get full text

Rivaroxaban: Expanded Role in Cardiovascular Disease Management—A Literature Review by Muhammad Ajmal, Jacob Friedman, Qurat Ul Ain Riaz Sipra, Tom Lassar

“…Direct oral anticoagulants (DOACs) are widely used for the prevention of stroke in nonvalvular atrial fibrillation, treatment of deep venous thrombosis and pulmonary embolism, and as prophylaxis after hip and knee surgery after approval by the Food and Drug Administration. In the last decade, DOACs were studied for various indications; this review is focused on rivaroxaban, a factor Xa inhibitor, which is used in an expanded evidence-based fashion for coronary artery disease, peripheral artery disease, heart failure, malignancy, and prophylaxis of deep venous thrombosis in acute medical illnesses.…”
Get full text

Anti-Nutritional Factors and Potassium Bromate Content in Bread and Flour Samples in Uyo Metropolis, Nigeria by A. S. Ekop, I. B. Obot, E. N. Ikpatt

“…The potassium bromate content was minimal in all the bread and flour samples and within safe limits of residual bromide found in flour as specified by the US Food and Drug Administration. The concentrations of the anti-nutritional factors in the bread and flour samples were partially different from each other when subjected to the students t-test statistics.…”
Get full text

Vancomycin-Associated Leukocytoclastic Vasculitis by Makhawadee Pongruangporn, David J. Ritchie, Dongsi Lu, Jonas Marschall

“…Vancomycin is U.S. Food and Drug Administration (FDA) approved for treatment of serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or in individuals who have failed, cannot tolerate, or are allergic to other antibiotics. …”
Get full text

Capture réglementaire en temps de pandémie by Samira Guennif

“…In the midst of the covid-19 pandemic, the Food and Drug Administration (FDA) published in March the orphan drug status granted to remdesivir, a molecule patented by Gilead as a treatment for the new coronavirus. …”
Get full text

Editorial: Host-diet-microbiome interactions in obesity prevention and treatment by Javad Barouei, Javad Barouei, Mary E. Kable, Mahta Moussavi, Mahta Moussavi, Yu-Hsin Hsieh

Get full text

The interaction between nirmatrelvir/ritonavir and sirolimus: a case report of a kidney recipient with renal insufficiency and COVID-19 by Yinhua Gong, Dan Shen, Jinfang Shi, Ye Jiang, Jie Gao

“…Nirmatrelvir/ritonavir is a novel drug combination authorized by the US Food and Drug Administration for the treatment of coronavirus disease 2019 (COVID-19). …”
Get full text

Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease by Scott D. Schoenberger, Stephen J. Kim

“…In recent years, the US Food and Drug Administration has approved new topical NSAIDs and previously approved NSAIDs have been reformulated. …”
Get full text

Embracing Generative Artificial Intelligence in Clinical Research and Beyond by Henry P. Foote, MD, Chuan Hong, PhD, Mohd Anwar, PhD, Maria Borentain, MD, Kevin Bugin, PhD, Nancy Dreyer, PhD, MPH, Josh Fessel, MD, PhD, Nitender Goyal, MD, Morgan Hanger, MPP, Adrian F. Hernandez, MD, Christoph P. Hornik, MD, PhD, MPH, Jennifer G. Jackman, PhD, MBA, Alistair C. Lindsay, MD, MPH, DPhil, Michael E. Matheny, MD, Kerem Ozer, MD, Jan Seidel, PhD, Norman Stockbridge, MD, PhD, Peter J. Embi, MD, Christopher J. Lindsell, PhD

Get full text

Evaluating the Safety and Usability of an Over-the-Counter Medical Device for Adults With Mild to Moderate Hearing Loss: Formative and Summative Usability Testing by Megan Elizabeth Salwei, Shilo Anders, Carrie Reale, Jason M Slagle, Todd Ricketts, Matthew B Weinger

“…ObjectiveWe evaluated the safety and usability of an over-the-counter hearing aid prior to Food and Drug Administration approval and market release. …”
Get full text

Worldwide Increasing Incidences of Cutaneous Malignant Melanoma by Dianne E. Godar

Get full text

Maximizing the Survival of Amyotrophic Lateral Sclerosis Patients: Current Perspectives by Osama A. Khairoalsindi, Ahmad R. Abuzinadah

“…The disease has a poor prognosis, with only two disease-modifying drugs approved by the United States Food and Drug Administration (FDA). The approved drugs for the disease have very limited survival benefits. …”
Get full text

IS IT POSSIBLE TO USE BEVACIZUMAB BIOSIMILAR IN ALL INDICATIONS REGISTERED FOR ORIGINAL DRUG? by S. V. Orlov, N. L. Shimanovskii, S. N. Fogt

“…Currently, the European Medicines Agency (EMA) and the Food and Drug Administration (FDA) have identified specific conditions under which for biosimilars extrapolation of indications is possible. …”
Get full text

Sugammadex-Associated Hypotension, Bradycardia, Asystole, and Death by Kazim Mirza, Kathryn Landoski, Dilip Thakar, Jagtar Heir-Singh, Timothy Jackson, Cynthia Kassab

“…On December 16, 2015, the Food and Drug Administration (FDA) in the United States approved sugammadex (Bridion, Merck and Co), a modified gamma-cyclodextrin, to be used as a reversal agent. …”
Get full text

Progress in Managing Heart Failure: an in-depth Review of Sacubitril/Valsartan Combination Therapy by Neeraj Hiremath, Jayasheela S. Hiremath, Sanatkumar B. Nyamagoud, Agadi Hiremath Viswanatha Swamy

“…The United States Food and Drug Administration has approved the drug’s use in treating patients with chronic heart failure with reduced ejection fraction (HFrEF). …”
Get full text

Corrigendum: Modeling flow in an in vitro anatomical cerebrovascular model with experimental validation by Saurabh Bhardwaj, Brent A. Craven, Jacob E. Sever, Francesco Costanzo, Francesco Costanzo, Scott D. Simon, Keefe B. Manning, Keefe B. Manning

Get full text

Pharma TARP: A Troubled Asset Relief Program for Novel, Abandoned Projects in the Pharmaceutical Industry by Tamas Bartfai, Graham Vaughan Lees

“…The authors propose a radical response by the U.S. government and the National Institutes of Health to rescue these abandoned projects, and to continue selected programs for drug approval by the U.S. Food and Drug Administration and the European Medicines Agency. …”
Get full text

Author Correction: Yindanxinnaotong, a Chinese compound medicine, synergistically attenuates atherosclerosis progress by Long Cheng, Guo-feng Pan, Xiao-dong Zhang, Jian-lu Wang, Wan-dan Wang, Jian-yong Zhang, Hui Wang, Ri-xin Liang, Xiao-bo Sun

Get full text